COMMUNIQUÉS West-GlobeNewswire

-
Complement 1 Appoints Dr. Christopher Cogle as Chief Medical Officer to Lead Clinical Strategy for Innovative Cancer Lifestyle Platform
21/05/2025 -
NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd
21/05/2025 -
Celeste Lajala Named Instructor of the Year by National Fitness Program, SilverSneakers, For Improving Senior Fitness in Hawaii
21/05/2025 -
Alumis Completes Merger with ACELYRIN
21/05/2025 -
Globally Recognized Expert in Rare Autoimmune Neurologic Diseases, Dr. Benjamin Greenberg, Joins Trethera Scientific Advisory Board
21/05/2025 -
GRI Bio to Participate in the Virtual Investor Closing Bell Series
21/05/2025 -
Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19
21/05/2025 -
SynVivo Appoints Dr. Richard Eglen to Board of Directors
21/05/2025 -
SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study
21/05/2025 -
Spinal Rehab & Sports Medicine Celebrates Two-Year Milestone of Dr. Josh Meyer, D.C.—Extending a Legacy of Excellence in Austin, TX
21/05/2025 -
Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference
21/05/2025 -
Best Place to Order Anavar USA 2025 | $25 Off + Fast US Ship
21/05/2025 -
EuroPCR 2025 : Des données récentes démontrent une réduction durable et statistiquement significative des taux d’événements avec le bioadaptateur DynamX® d’Elixir Medical par rapport au stent à élution médicamenteuse (SEM) sur trois ans
21/05/2025 -
EuroPCR 2025: Late-Breaking Data Demonstrate Sustained Significantly Lower Event Rates With Elixir Medical’s DynamX Bioadaptor Over Drug-Eluting Stent Through Three Years
21/05/2025 -
Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals
21/05/2025 -
Biodesix to Participate in Upcoming Investor Conferences
21/05/2025 -
Verona Pharma Announces June 2025 Investor Conference Participation
21/05/2025 -
Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases
21/05/2025 -
GenVivo Highlights Non-Integrating Retroviral Vector Technology with Persistent Payload Expression at the 2025 Retroviruses Meeting
21/05/2025
Pages